This podcast episode explores the transformative potential of gene therapy, particularly through innovative treatments like CRISPR-Cas9, while addressing the overwhelming financial burdens they impose on healthcare systems, particularly in the US. It calls for collaborative efforts from governments and pharmaceutical companies to devise sustainable pricing models that support broad access to these therapies. Additionally, the episode highlights The Economist's Espresso app, which has recently made itself free for students and incorporates AI-driven translations, reflecting a commitment to reaching a wider, younger audience and promoting quality journalism.
